FDA Backpedals False Ivermectin Claims, Ineffective Flu Shots, Need for Vaccine Risk Stratification

Emerald Robinson host of The Absolute Truth reviews the lawsuit by Drs. Bowden, Marik, and Apter against the US FDA for making false and misleading claims about ivermectin. The FDA along with the AMA were engaged in a campaign to abolish the use of ivermectin, one of the most rapidly effective drugs for acute COVID-19. Under court pressure the FDA removed their false material projected to the public. Dr. McCullough who has extensively used ivermectin including it in the published McCullough Protocol said the drug was safe and effective and the FDA deserved the lawsuit. They also covered the miserable efficacy of influenza vaccines and the overall need to reduce the burden of vaccines on children and adults with risk stratification. This would be a targeted approach for those who would benefit from the modest efficacy with most vaccines. Courtesy The Absolute Truth November 22, 2022.

Citation

McCullough PA, Alexander PE, Armstrong R, Arvinte C, Bain AF, Bartlett RP, Berkowitz RL, Berry AC, Borody TJ, Brewer JH, Brufsky AM, Clarke T, Derwand R, Eck A, Eck J, Eisner RA, Fareed GC, Farella A, Fonseca SNS, Geyer CE Jr, Gonnering RS, Graves KE, Gross KBV, Hazan S, Held KS, Hight HT, Immanuel S, Jacobs MM, Ladapo JA, Lee LH, Littell J, Lozano I, Mangat HS, Marble B, McKinnon JE, Merritt LD, Orient JM, Oskoui R, Pompan DC, Procter BC, Prodromos C, Rajter JC, Rajter JJ, Ram CVS, Rios SS, Risch HA, Robb MJA, Rutherford M, Scholz M, Singleton MM, Tumlin JA, Tyson BM, Urso RG, Victory K, Vliet EL, Wax CM, Wolkoff AG, Wooll V, Zelenko V. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med. 2020 Dec 30;21(4):517-530. doi: 10.31083/j.rcm.2020.04.264. PMID: 33387997.